Thursday Nov 21
Applied Clinical Trials
Paper Published in American Journal of Cardiology Demonstrates...
Evaluations of vascular healing taken at multiple time points demonstrated excellent vessel healing with a low rate of neoatherosclerosis.
Angiographic and clinical comparison of novel Orsiro Hybrid...
The Orsiro Hybrid sirolimus-eluting stent is a newly developed third-generation drug-eluting stent, featuring a unique dual-polymer mix.
Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNEA ...
Pfizer Inc. announced today top-line results from a Phase 3B/4 study of RAPAMUNE evaluating kidney transplant patients who transitioned from tacrolimus-based therapy to RAPAMUNE 3 to 5 months after transplant.
Investigators at University Hospital Report New Data on Cyclosporins
An API 4000 [tandem mass spectrometer system were applied for the direct liquid chromatography-tandem mass spectrometric assay analysis using electrospray ionization in positive ion mode."
Stentys Reports Sirolimus-Eluting Stent Study
According to a release, the Apposition IV trial enrolled 152 patients suffering from ST-elevation Myocardial Infarction in a double-randomized trial to compare the Stentys Sirolimus-eluting stent to Resolute zotarolimus-eluting stent at two different time points, four and nine months, evaluating stent apposition and strut coverage under ... (more)